Intraoperative Ketamine for Chronic Postoperative Pain After Open-Heart Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorBursa City Hospital

About this trial

The goal of this interventional study is to determine whether a single intraoperative IV dose of ketamine can reduce postoperative chronic and acute pain and postoperative opioid requirements in adult patients undergoing open-heart surgery under general anesthesia. The main questions it aims to answer are:

Primary outcome: Does a single-dose intraoperative IV ketamine reduce the presence and severity of pain at 3 and 6 months after surgery ? Secondary outcomes: Does it reduce acute postoperative pain scores, opioid consumption, and other recovery-related outcomes in the early postoperative period ? Researchers will compare a single-dose IV ketamine arm to a placebo arm to see if ketamine decreases chronic pain incidence at 3 and 6 months and improves acute pain/opioid-related outcomes.

Participants will:

Be randomized to receive either a single IV bolus of ketamine or placebo during surgery.

Undergo standard general anesthesia and open cardiac surgery per protocol. Have postoperative pain assessed using Numeric Rating Scale (NRS) at extubation, 0, 3, 6, 12, 24, and 48 hours.

Have opioid and additional analgesic use recorded, time to first rescue analgesic noted, and ICU/hospital length of stay tracked.

Be evaluated for ICU delirium (CAM-ICU) and complete Quality of Recovery-15, Brief Pain Inventory-Short Form, and Pain Self-Efficacy questionnaires.

Be followed up at 3 and 6 months for assessment of chronic postoperative pain.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

ASA II-III,

Patients scheduled for elective on-pump open cardiac surgery via median sternotomy.

Disqualifiers

Emergency surgery requirement

Need for reoperation

Requirement for postoperative re-intubation

History of opioid use

Trial design

Design model

Parallel

Treatments tested in this trial

  • Ketamine group

    Other intervention

    Ketamine group: Single IV bolus of ketamine 1 mg/kg administered after induction of anesthesia and prior to skin incision

  • Control Group

    Other intervention

    Control group: Single IV bolus of normal saline (placebo) labeled as study drug administered after induction of anesthesia and prior to skin incision.

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: Ketamine GroupExperimental treatment 1 intervention
Group B: Control GroupPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Presence of postoperative chronic pain at 3 months

Incidence of persistent postoperative pain at 3 months.

Time frame
From the day of surgery through 6 months postoperatively.
2

Presence of postoperative chronic pain at 6 months

Incidence of persistent postoperative pain at 6 months.

Time frame
From the day of surgery to 6 months postoperatively.

Secondary outcomes

1

Pain scores (Numeric Rating Scale ) at extubation and at 0, 3, 6, 12, 24, and 48 hours post-extubation

Pain scores (Numeric Rating Scale ) at extubation and at 0, 3, 6, 12, 24, and 48 hours post-extubation The Numeric Rating Scale (NRS) is the most commonly used subjective pain assessment tool in which patients express pain intensity by choosing a number between 0 and 10 (or 0-100). 0 represents "no pain" and 10 represents "unbearable/worst pain," providing a quick, simple measure. 0 = no pain; 1-3 = mild; 4-6 = moderate; 7-10 = severe.

Time frame
Two days starting from the day of surgery the day of enrollment
2

Time to first rescue analgesic request

Intravenous morphine 0.05 mg/kg will be used as rescue analgesia.

Time frame
When the day of surgery is considered Day 1, it will be applied from the time the patient is admitted to the postoperative ICU until discharge from the ICU, for a maximum of 2 weeks.
3

ICU delirium assessed by CAM-ICU

Delirium in the ICU will be assessed using the CAM-ICU and documented.

Time frame
When the day of surgery is considered Day 1, it will be applied daily from the time the patient is admitted to the postoperative ICU until discharge from the ICU, for a maximum of 2 weeks.
4

Quality of Recovery-15 (QoR-15)

Prior to discharge, the Quality of Recovery-15 (QoR-15) questionnaire will be administered and scored. The QoR-15 (Quality of Recovery-15) is a 15-item patient-reported questionnaire that measures postoperative recovery across five domains: physical comfort, emotional state, physical independence, psychological support, and pain. Each item is scored on an 11-point numeric scale (0-10). Scoring: Item range: 0 to 10. Total score range: 0 to 150 (sum of 15 item. Higher scores indicate better recovery (i.e., higher quality of recovery)

Time frame
When the day of surgery is considered Day 1, it will be applied on the day of hospital discharge, for a maximum of 4 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Bursa City Hospital

Lead sponsor

Bursa Sehir Hastanesi

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: